2.53
price up icon1.61%   0.04
after-market After Hours: 2.53
loading
Cumberland Pharmaceuticals Inc stock is traded at $2.53, with a volume of 102.61K. It is up +1.61% in the last 24 hours and up +18.22% over the past month. Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$2.49
Open:
$2.51
24h Volume:
102.61K
Relative Volume:
1.82
Market Cap:
$37.84M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-3.4658
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
+5.86%
1M Performance:
+18.22%
6M Performance:
-56.83%
1Y Performance:
+16.06%
1-Day Range:
Value
$2.4192
$2.66
1-Week Range:
Value
$2.17
$2.73
52-Week Range:
Value
$1.85
$7.25

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Name
Name
Cumberland Pharmaceuticals Inc
Name
Phone
615-255-0068
Name
Address
1600 WEST END AVENUE, NASHVILLE,, TN
Name
Employee
91
Name
Twitter
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
CPIX's Discussions on Twitter

Compare CPIX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CPIX
Cumberland Pharmaceuticals Inc
2.53 37.24M 37.79M -10.38M -1.00M -0.73
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
118.66 51.85B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.33 45.46B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.52 42.70B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
29.79 34.62B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
493.99 21.03B 3.08B 1.24B 1.07B 25.61

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-12-12 Reiterated UBS Neutral
Feb-01-11 Reiterated UBS Neutral
Dec-16-10 Downgrade UBS Buy → Neutral
Aug-17-10 Downgrade Jefferies Buy → Hold
Aug-17-10 Reiterated Morgan Joseph Buy
Aug-17-10 Reiterated UBS Buy
May-14-10 Reiterated Morgan Joseph Buy
View All

Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News

pulisher
Dec 11, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Shares Fly 26% But Investors Aren't Buying For Growth - simplywall.st

Dec 11, 2025
pulisher
Dec 08, 2025

Cumberland Pharmaceuticals Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Dec 08, 2025
pulisher
Dec 08, 2025

Cumberland (Nasdaq: CPIX) gets CMS price-linked J-code for Caldolor injection - Stock Titan

Dec 08, 2025
pulisher
Dec 08, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) versus Pyxis Oncology (NASDAQ:PYXS) Critical Comparison - Defense World

Dec 08, 2025
pulisher
Dec 05, 2025

Is Cumberland Pharmaceuticals Inc. stock cheap compared to fundamentals2025 Market Outlook & Risk Managed Investment Strategies - Newser

Dec 05, 2025
pulisher
Dec 03, 2025

CPIX SEC FilingsCumberland Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 03, 2025
pulisher
Dec 02, 2025

What is the fair value of Cumberland Pharmaceuticals Inc. stock now2025 Top Gainers & Daily Price Action Insights - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

How strong is Cumberland Pharmaceuticals Inc. stock revenue growth2025 Trading Volume Trends & Fast Moving Trade Plans - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Debt In A Risky Way? - simplywall.st

Nov 30, 2025
pulisher
Nov 29, 2025

Cumberland Pharmaceuticals Inc Stock Analysis and ForecastMarket Breadth Indicators & Breakout Portfolio Performance - earlytimes.in

Nov 29, 2025
pulisher
Nov 27, 2025

Hepatic Encephalopathy Market Analysis and Forecast, 2025-2035 - GlobeNewswire Inc.

Nov 27, 2025
pulisher
Nov 26, 2025

Nasdaq Moves: Is Cumberland Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Reactions & Stock Market Timing Techniques - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 24, 2025

Cumberland Pharmaceuticals Inc. Announces First Amendment to Amended and Restated Revolving Credit Note and Second Amendment to Amended and Restated Revolving Credit Loan Agreement - marketscreener.com

Nov 24, 2025
pulisher
Nov 24, 2025

Is Cumberland Pharmaceuticals Inc a good long term investmentTrendline Breakouts & Grow Smarter With Pro-Level Research - earlytimes.in

Nov 24, 2025
pulisher
Nov 21, 2025

Cumberland Pharmaceuticals Inc. (CPIX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

CPIX amends Pinnacle Bank revolver, $25M capacity, SOFR +2.75% - Stock Titan

Nov 21, 2025
pulisher
Nov 20, 2025

How Cumberland Pharmaceuticals Inc. stock performs in interest rate cyclesJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Cumberland Pharmaceuticals Inc. stock positioned for long term growthJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Cumberland Pharmaceuticals Inc. forming a reversal patternMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Cumberland Pharmaceuticals Inc. stock valuations compare to rivalsJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Cumberland Pharmaceuticals Inc. stock safe for conservative investorsJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Cumberland Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Visual analytics tools that track Cumberland Pharmaceuticals Inc. performanceWeekly Market Report & Daily Technical Forecast Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Expansions - MSN

Nov 18, 2025
pulisher
Nov 18, 2025

Price action breakdown for Cumberland Pharmaceuticals Inc.Market Volume Report & Entry Point Confirmation Signals - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

How to forecast Cumberland Pharmaceuticals Inc. trends using time series2025 Pullback Review & Weekly Market Pulse Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Can Cumberland Pharmaceuticals Inc. stock sustain institutional interestMarket Trend Summary & Consistent Profit Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Cumberland Pharmaceuticals Partners with RedHill for Talicia - MSN

Nov 17, 2025
pulisher
Nov 17, 2025

Regression analysis insights on Cumberland Pharmaceuticals Inc. performanceGold Moves & Accurate Intraday Trade Tips - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Why Cumberland Pharmaceuticals Inc. stock is trending among retail tradersJuly 2025 Setups & Detailed Earnings Play Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Applying chart zones and confluence areas to Cumberland Pharmaceuticals Inc.Earnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Why Cumberland Pharmaceuticals Inc. stock is rated strong buy2025 Earnings Impact & Precise Swing Trade Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Has Cumberland Pharmaceuticals Inc. formed a bullish divergenceWeekly Trade Review & Safe Entry Momentum Stock Tips - newser.com

Nov 15, 2025

Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.21
price down icon 1.48%
$21.29
price up icon 0.09%
drug_manufacturers_specialty_generic RDY
$14.02
price down icon 0.50%
$11.65
price up icon 0.52%
$152.80
price down icon 1.26%
$493.99
price up icon 1.12%
Cap:     |  Volume (24h):